Express Medicine Limited 13942318 false 2022-02-25 2023-02-28 2023-02-28 The principal activity of the company is Other human health activities Digita Accounts Production Advanced 6.30.9574.0 true 13942318 2022-02-25 2023-02-28 13942318 2023-02-28 13942318 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 13942318 bus:Micro-entities 2022-02-25 2023-02-28 13942318 bus:AuditExemptWithAccountantsReport 2022-02-25 2023-02-28 13942318 bus:FullAccounts 2022-02-25 2023-02-28 13942318 bus:SmallCompaniesRegimeForAccounts 2022-02-25 2023-02-28 13942318 bus:RegisteredOffice 2022-02-25 2023-02-28 13942318 bus:Director1 2022-02-25 2023-02-28 13942318 bus:Director2 2022-02-25 2023-02-28 13942318 bus:PrivateLimitedCompanyLtd 2022-02-25 2023-02-28 13942318 countries:AllCountries 2022-02-25 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 13942318

Express Medicine Limited

Annual Report and Unaudited Financial Statements

for the Period from 25 February 2022 to 28 February 2023

 

Express Medicine Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

2

 

Express Medicine Limited

Company Information

Directors

Mr Leigh Rogers

Dr Rory Irwin

Registered office

20 Stafford Street
Eccleshall
Stafford
ST21 6BH

 

Express Medicine Limited

Balance Sheet

(Registration number: 13942318)
Balance Sheet as at 28 February 2023

2023
£

 

Current assets

448

 

Prepayments and accrued income

100

 

Creditors: Amounts falling due within one year

(4,517)

Total assets less current liabilities

(3,969)

 

Accruals and deferred income

(400)

 

(4,369)

 

Capital and reserves

(4,369)

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
20 Stafford Street
Eccleshall
Stafford
ST21 6BH

These financial statements were authorised for issue by the Board on 13 November 2023.

1.1

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 0.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial period ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Express Medicine Limited

Balance Sheet

(Registration number: 13942318)
Balance Sheet as at 28 February 2023

Approved and authorised by the Board on 13 November 2023 and signed on its behalf by:
 

.........................................

Mr Leigh Rogers
Director

.........................................

Dr Rory Irwin
Director